Penumbra, Inc. NYSE:PEN

Founder-led company

Penumbra stock price today

$248.94
+9.09
+3.79%
Financial Health
0
1
2
3
4
5
6
7
8
9

Penumbra stock price monthly change

+25.69%
month

Penumbra stock price quarterly change

+25.69%
quarter

Penumbra stock price yearly change

-7.83%
year

Penumbra key metrics

Market Cap
9.22B
Enterprise value
11.06B
P/E
-5733
EV/Sales
13.06
EV/EBITDA
390.38
Price/Sales
12.86
Price/Book
10.91
PEG ratio
42.24
EPS
2.41
Revenue
1.09B
EBITDA
125.18M
Income
93.39M
Revenue Q/Q
15.43%
Revenue Y/Y
23.86%
Profit margin
-0.24%
Oper. margin
0.72%
Gross margin
63.18%
EBIT margin
0.72%
EBITDA margin
11.42%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Penumbra stock price history

Penumbra stock forecast

Penumbra financial statements

Average Price Target
Last Year

$237.56

Potential downside: -4.57%

Based on estimate of 8 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Penumbra, Inc. (NYSE:PEN): Profit margin
Jun 2023 261.49M 18.96M 7.25%
Sep 2023 270.94M 9.21M 3.4%
Dec 2023 284.67M 54.21M 19.05%
Mar 2024 278.65M 11.00M 3.95%
Penumbra, Inc. (NYSE:PEN): Debt to assets
Jun 2023 1432532000 365.98M 25.55%
Sep 2023 1468377000 364.23M 24.81%
Dec 2023 1556305000 377.36M 24.25%
Mar 2024 1579845000 376.31M 23.82%
Penumbra, Inc. (NYSE:PEN): Cash Flow
Jun 2023 17.09M -6.67M 8.69M
Sep 2023 30.84M -44.39M 212K
Dec 2023 36.26M 24.28M 5.92M
Mar 2024 38.29M 18.38M -794K

Penumbra alternative data

Penumbra, Inc. (NYSE:PEN): Employee count
Sep 2023 3,900
Oct 2023 3,900
Nov 2023 3,900
Dec 2023 3,900
Jan 2024 3,900
Feb 2024 3,900
Mar 2024 4,200
Apr 2024 4,200
May 2024 4,200
Jun 2024 4,200
Jul 2024 4,200

Penumbra other data

79.38% -0.30%
of PEN is owned by hedge funds
30.72M +887.01K
shares is hold by hedge funds

Penumbra, Inc. (NYSE:PEN): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 255
Mar 2024 0 8878
Apr 2024 0 770
May 2024 0 15600
Jun 2024 0 600
Jul 2024 0 15770
Aug 2024 0 30600
Sep 2024 0 16382
Oct 2024 0 15936
Nov 2024 0 17398
Dec 2024 0 16254
Transaction Date Insider Security Shares Price per share Total value Source
Sale
ELSESSER ADAM director, officer.. Common Stock 800 $240.79 $192,632
Sale
ELSESSER ADAM director, officer.. Common Stock 4,038 $242.1 $977,600
Sale
ELSESSER ADAM director, officer.. Common Stock 5,435 $242.94 $1,320,379
Sale
ELSESSER ADAM director, officer.. Common Stock 3,698 $243.91 $901,979
Sale
ELSESSER ADAM director, officer.. Common Stock 1,029 $244.75 $251,848
Option
SHIU LAMBERT officer: Chief Ac.. Common Stock 5,250 $12.36 $64,890
Option
SHIU LAMBERT officer: Chief Ac.. Stock Option (right to buy) 5,250 $12.36 $64,890
Sale
ROBERTS JOHANNA officer: EVP, Gen.. Common Stock 36 $242.5 $8,730
Sale
ROBERTS JOHANNA officer: EVP, Gen.. Common Stock 106 $243.24 $25,783
Sale
ROBERTS JOHANNA officer: EVP, Gen.. Common Stock 177 $244.61 $43,296
Patent
Application
Filling date: 4 Mar 2022 Issue date: 8 Sep 2022
Grant
Filling date: 7 Apr 2021 Issue date: 6 Sep 2022
Grant
Filling date: 5 Jun 2018 Issue date: 6 Sep 2022
Grant
Filling date: 22 Feb 2019 Issue date: 30 Aug 2022
Grant
Filling date: 10 Dec 2018 Issue date: 2 Aug 2022
Grant
Filling date: 30 Jun 2020 Issue date: 19 Jul 2022
Grant
Filling date: 27 Jun 2019 Issue date: 19 Jul 2022
Grant
Filling date: 28 Jul 2021 Issue date: 24 May 2022
Application
Filling date: 6 Dec 2021 Issue date: 24 Mar 2022
Application
Filling date: 22 Jul 2021 Issue date: 3 Feb 2022
Wednesday, 25 December 2024
zacks.com
Monday, 23 December 2024
zacks.com
Friday, 20 December 2024
zacks.com
Wednesday, 18 December 2024
zacks.com
Tuesday, 17 December 2024
benzinga.com
Monday, 16 December 2024
zacks.com
Monday, 9 December 2024
zacks.com
Friday, 6 December 2024
zacks.com
Tuesday, 3 December 2024
zacks.com
Friday, 29 November 2024
zacks.com
zacks.com
Tuesday, 26 November 2024
zacks.com
Thursday, 21 November 2024
zacks.com
Wednesday, 20 November 2024
prnewswire.com
Tuesday, 5 November 2024
zacks.com
zacks.com
prnewswire.com
Thursday, 31 October 2024
zacks.com
Wednesday, 30 October 2024
seekingalpha.com
zacks.com
zacks.com
prnewswire.com
Wednesday, 23 October 2024
zacks.com
Monday, 14 October 2024
fool.com
prnewswire.com
Wednesday, 9 October 2024
zacks.com
Wednesday, 2 October 2024
prnewswire.com
Tuesday, 24 September 2024
zacks.com
Wednesday, 18 September 2024
fool.com
Tuesday, 17 September 2024
zacks.com
  • What's the price of Penumbra stock today?

    One share of Penumbra stock can currently be purchased for approximately $248.94.

  • When is Penumbra's next earnings date?

    Unfortunately, Penumbra's (PEN) next earnings date is currently unknown.

  • Does Penumbra pay dividends?

    No, Penumbra does not pay dividends.

  • How much money does Penumbra make?

    Penumbra has a market capitalization of 9.22B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.95% to 1.06B US dollars.

  • What is Penumbra's stock symbol?

    Penumbra, Inc. is traded on the NYSE under the ticker symbol "PEN".

  • What is Penumbra's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Penumbra?

    Shares of Penumbra can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Penumbra's key executives?

    Penumbra's management team includes the following people:

    • Ms. Maggie S. Yuen Chief Financial Officer(age: 53, pay: $519,040)
    • Ms. Johanna Roberts Executive Vice President, Gen. Counsel & Sec.(age: 53, pay: $441,930)
    • Mr. Lambert Shiu Chief Accounting Officer(age: 45, pay: $413,210)
    • Mr. Adam Elsesser Co-Founder, Chairman, Pres & Chief Executive Officer(age: 63, pay: $219,030)
  • Is Penumbra founder-led company?

    Yes, Penumbra is a company led by its founder Mr. Adam Elsesser.

  • How many employees does Penumbra have?

    As Jul 2024, Penumbra employs 4,200 workers.

  • When Penumbra went public?

    Penumbra, Inc. is publicly traded company for more then 9 years since IPO on 18 Sep 2015.

  • What is Penumbra's official website?

    The official website for Penumbra is penumbrainc.com.

  • Where are Penumbra's headquarters?

    Penumbra is headquartered at One Penumbra Place, Alameda, CA.

  • How can i contact Penumbra?

    Penumbra's mailing address is One Penumbra Place, Alameda, CA and company can be reached via phone at +51 07483200.

  • What is Penumbra stock forecast & price target?

    Based on 8 Wall Street analysts` predicted price targets for Penumbra in the last 12 months, the avarage price target is $237.56. The average price target represents a -4.57% change from the last price of $248.94.

Penumbra company profile:

Penumbra, Inc.

penumbrainc.com
Exchange:

NYSE

Full time employees:

4,200

Industry:

Medical - Devices

Sector:

Healthcare

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

One Penumbra Place
Alameda, CA 94502

CIK: 0001321732
ISIN: US70975L1070
CUSIP: 70975L107